DJIA 18,053.71 23.50 0.13%
NASDAQ 4,806.86 33.39 0.70%
S&P 500 2,088.77 6.89 0.33%
market minute promo

34.24 0.10 (0.29%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

WX $34.24 0.29%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $34.30
Previous Close $34.14
Daily Range $34.00 - $34.50
52-Week Range $29.84 - $40.72
Market Cap $2.4B
P/E Ratio 20.82
Dividend (Yield) $0.00 (0.0%)
Volume 277,060
Average Daily Volume 308,697
Current FY EPS $1.54

Sector

Healthcare

Industry

Drugs

WuXi PharmaTech (Cayman), Inc. (ADR) (WX) Description

China-based pharmaceutical and biotechnology R&D outsourcing company which provides a integrated portfolio of laboratory and manufacturing services in the drug discovery and development process to pharmaceutical and biotechnology companies. Website: http://www.wuxiapptec.com/

News & Commentary Rss Feed

Why WuXi PharmaTech (Cayman), Inc. (ADR) Shares Crashed

Is this meaningful or just another movement?

Wuxi Pharmatech Cayman Breaks Above 200-Day Moving Average - Bullish for WX

Top 4 Mid-Cap Stocks In The Medical Laboratories & Research Industry With The Lowest PEG Ratio

WuXi PharmaTech Subsidiary Submits Application To The National Equities Exchange And Quotations In C

WuXi PharmaTech Subsidiary Submits Application To The National Equities Exchange And Quotations In China to List On The New Third Board

Week In Review: BeiGene Announces $75 Million Series A Fundraising

WuXi PharmaTech's (WX) CEO Ge Li on Q3 2014 Results - Earnings Call Transcript

Earnings Reaction History: WuXi PharmaTech, 50.0% Follow-Through Indicator, 4.0% Sensitive

Top 4 NYSE Stocks In The Medical Laboratories & Research Industry With The Highest ROE

Week In Review: Roche Seeks China Partners With First-In-Class, Best-In-Class Products

WuXi Congratulates TaiMed Biologics On Receiving Orphan Drug Designation For Ibalizumab From U.S. FD

WuXi Congratulates TaiMed Biologics On Receiving Orphan Drug Designation For Ibalizumab From U.S. FDA

Foundation Medicine And WuXi PharmaTech Announce Strategic Collaboration To Offer Best-in-Class Comp

Foundation Medicine And WuXi PharmaTech Announce Strategic Collaboration To Offer Best-in-Class Comprehensive Genomic Profiling in China

See More WX News...

WX's Top Competitors

WX $34.24 (0.29%)
Current stock: WX
TMO $127.67 (0.69%)
Current stock: TMO
ILMN $188.20 (1.06%)
Current stock: ILMN
WAT $114.35 (-0.17%)
Current stock: WAT